Condition
Secondary Osteoporosis
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07325149Not ApplicableNot Yet RecruitingPrimary
The Effect of Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation on Bone Strength.
NCT03029442Phase 4TerminatedPrimary
The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
NCT03930992Phase 3CompletedPrimary
Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men
NCT03811873Not ApplicableCompleted
Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates
Showing all 4 trials